Archive
Dis-Chem Insurance Branding Non-Compliant says CMS
Dis-Chem health insurance branding issues raise enforcement risk for Centriq’s MyHealth products and potential disruption for policyholders.
Read More
National Health Insurance Negotiations: SAMA Seeks NHI Talks
National Health Insurance Negotiations: SAMA meets Motsoaledi after Godongwana urges NHI litigants to seek a settlement.
Read More
NHI Truce Talks: Godongwana Pushes Settlement On NHI
NHI truce talks could end court battles and shift focus to workable reforms for universal health coverage.
Read More
Afrox Unpaid Invoices: Lawsuit Exposes Provincial Health Debt
Afrox Unpaid Invoices spark a R360m lawsuit, highlighting growing hospital debt, late payments, and risks to essential medical gas supplies.
Read More
NHI Court Challenges: Litigants Reject Settlement Call
The NHI Court Challenge crisis deepens as key litigants reject Enoch Godongwana’s settlement push, citing flawed consultation.
Read More
2026 Healthcare Watchlist: Nine Healthcare Stories to Track
Spotlight’s 2026 Healthcare Watchlist highlights nine health topics, from a new HIV prevention jab to NHI court battles and aid shocks.
Read More
Sizwe Hosmed Regulatory Allegations: Claims of Sabotage
Sizwe Hosmed’s regulatory allegations highlight claims of corruption, sabotage and racial bias in South Africa’s medical scheme industry.
Read More
Generic Semaglutide Set to Disrupt Global GLP‑1 Market
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.
Read More
NHI Legal Challenges: Talks Stalled by Politics, Funding Gaps
Finance Minister Enoch Godongwana urged a truce in the NHI legal challenges, but political fault lines keep negotiations fragile.
Read More
NHI Legal Challenges: Minister Calls For Out‑Of‑Court Resolution
Finance Minister Godongwana urges the settlement of NHI legal challenges to fast‑track universal healthcare and ease delays from court cases.
Read More
US Healthcare Spending Rose Sharply to $5.3 Trillion in 2024
US healthcare spending in 2024 jumped 7.2% to $5.3 trillion, driven by rising insurance enrolment, service use, and administrative costs.
Read More
Aspen Pharmacare Business Sale Sparks Investor Optimism
Aspen Pharmacare business sale boosts investor confidence. A strategic pivot following a turbulent 2025 rebuilds financial flexibility.
Read More